[Current problems in etiotropic therapy of mycoses].
Buslaeva
G N
GN
Russian State Medical University, Moscow.
D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002174:Candicidin / Q000009:adverse effects / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D015725:Fluconazole / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000627:therapeutic use; D008825:Miconazole / Q000009:adverse effects / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology; D009761:Nystatin / Q000009:adverse effects / Q000627:therapeutic use
D000935:Antifungal Agents; D009761:Nystatin; D002174:Candicidin; D017964:Itraconazole; D008825:Miconazole; D000666:Amphotericin B; D015725:Fluconazole
Sovremennye problemy étiotropnoĭ terapii mikozov.